Valuing a company is the cornerstone of investment banking. Whether advising on mergers, acquisitions, or capital raises, I rely on three core valuation methods: Discounted Cash Flow (DCF), Comparable Company Analysis (Comps), and Precedent Transactions. Each has strengths, weaknesses, and specific use cases. In this guide, I break down these methods with real-world examples, mathematical rigor, and practical insights.
Table of Contents
1. Discounted Cash Flow (DCF) Analysis
The DCF model estimates a company’s intrinsic value by forecasting its future cash flows and discounting them to present value. The logic is simple: a dollar today is worth more than a dollar tomorrow.
Key Steps in DCF Valuation
- Project Free Cash Flows (FCF) – Estimate the company’s unlevered FCF over a 5-10 year period.
- Determine Terminal Value (TV) – Calculate the value beyond the forecast period using either the Gordon Growth Model or Exit Multiple approach.
- Discount Cash Flows – Apply a discount rate (Weighted Average Cost of Capital, WACC) to bring future cash flows to present value.
Mathematical Framework
The DCF formula is:
DCF = \sum_{t=1}^{n} \frac{FCF_t}{(1 + WACC)^t} + \frac{TV}{(1 + WACC)^n}Where:
- FCF_t = Free Cash Flow in year t
- WACC = Weighted Average Cost of Capital
- TV = Terminal Value
Calculating WACC
WACC = \left( \frac{E}{V} \times r_e \right) + \left( \frac{D}{V} \times r_d \times (1 - T) \right)Where:
- E = Market value of equity
- D = Market value of debt
- V = E + D
- r_e = Cost of equity (from CAPM)
- r_d = Cost of debt
- T = Corporate tax rate
Example: Valuing a Tech Startup
Assume a SaaS company with:
- Year 1 FCF = $5M
- Growth rate = 10% for 5 years
- Terminal growth = 3%
- WACC = 12%
| Year | FCF ($M) | PV Factor (@12%) | Present Value ($M) |
|---|---|---|---|
| 1 | 5.0 | 0.893 | 4.465 |
| 2 | 5.5 | 0.797 | 4.384 |
| 3 | 6.05 | 0.712 | 4.308 |
| 4 | 6.655 | 0.636 | 4.232 |
| 5 | 7.321 | 0.567 | 4.151 |
| TV | 94.4 | 0.567 | 53.5 |
| Total DCF | 75.04 |
The company’s enterprise value is ~$75M.
Strengths & Weaknesses
✔ Intrinsic value – Independent of market sentiment.
✔ Flexible – Adaptable to different growth scenarios.
✖ Sensitive to assumptions – Small changes in WACC or growth rates skew results.
2. Comparable Company Analysis (Comps)
Comps benchmark a company against similar publicly traded peers. The idea is that firms in the same industry should trade at similar multiples.
Key Steps
- Select Comparable Companies – Same industry, size, and growth profile.
- Calculate Valuation Multiples – EV/EBITDA, P/E, EV/Sales, etc.
- Apply Multiples to Target – Derive implied valuation.
Example: Retail Company Valuation
Assume we’re valuing RetailCo, a mid-sized apparel retailer. We gather data on three peers:
| Company | EV ($B) | EBITDA ($B) | EV/EBITDA (x) |
|---|---|---|---|
| Peer A | 12.0 | 1.5 | 8.0 |
| Peer B | 8.0 | 1.0 | 8.0 |
| Peer C | 10.0 | 1.2 | 8.3 |
| Median | 8.0 |
If RetailCo has EBITDA of $900M, its implied EV is:
EV = EBITDA \times Median\ Multiple = 900 \times 8.0 = \$7.2BStrengths & Weaknesses
✔ Market-based – Reflects current investor sentiment.
✔ Quick & intuitive – Easy to explain to clients.
✖ Limited by comparables – Hard to find perfect matches.
3. Precedent Transactions Analysis
This method looks at past M&A deals in the same industry to gauge valuation benchmarks.
Key Steps
- Identify Relevant Transactions – Recent deals with similar targets.
- Extract Multiples – EV/Revenue, EV/EBITDA, etc.
- Apply to Target – Estimate valuation range.
Example: Pharma Acquisition
Suppose a pharma company was acquired for:
- Transaction EV: $20B
- EBITDA: $2.5B
- Implied EV/EBITDA: 8.0x
If another pharma firm has EBITDA of $1.8B, its rough valuation would be:
EV = 1.8 \times 8.0 = \$14.4BStrengths & Weaknesses
✔ Real-world benchmarks – Based on actual deal prices.
✔ Includes control premium – M&A deals often pay a premium.
✖ Outdated data – Past deals may not reflect current market conditions.
Which Method Should You Use?
| Method | Best For | Limitations |
|---|---|---|
| DCF | Long-term intrinsic value | Highly sensitive to inputs |
| Comps | Relative market valuation | Requires good comparables |
| Precedent Transactions | M&A pricing | Limited by deal availability |
In practice, I use all three to triangulate a fair value range.
Final Thoughts
Valuation is both an art and a science. While models provide structure, judgment plays a key role. Always stress-test assumptions and cross-validate with multiple methods. If you master these three techniques, you’ll have a robust framework for investment banking valuations.
